Cargando…

Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions

The recent demonstration of human glandular kallikrein (hK2) expression in a breast carcinoma cell line has suggested that this putatively prostate-restricted, steroid hormone-regulated protease may also be expressed in breast epithelium in vivo and secreted into the mammary duct system. Given that...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, M H, Magklara, A, Obiezu, C, Levesque, M A, Sutherland, D J A, Tindall, D J, Young, C Y F, Sauter, E R, Diamandis, E P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363279/
https://www.ncbi.nlm.nih.gov/pubmed/10646889
http://dx.doi.org/10.1054/bjoc.1999.0927
_version_ 1782153664067010560
author Black, M H
Magklara, A
Obiezu, C
Levesque, M A
Sutherland, D J A
Tindall, D J
Young, C Y F
Sauter, E R
Diamandis, E P
author_facet Black, M H
Magklara, A
Obiezu, C
Levesque, M A
Sutherland, D J A
Tindall, D J
Young, C Y F
Sauter, E R
Diamandis, E P
author_sort Black, M H
collection PubMed
description The recent demonstration of human glandular kallikrein (hK2) expression in a breast carcinoma cell line has suggested that this putatively prostate-restricted, steroid hormone-regulated protease may also be expressed in breast epithelium in vivo and secreted into the mammary duct system. Given that the only substrate yet identified for hK2 activity is the precursor of prostate-specific antigen (PSA), the expression of which in breast carcinomas may be associated with favourable prognosis, our purpose was to examine the expression pattern of both hK2 and PSA in breast tumour tissues. Cytosolic extracts of 336 primary breast carcinomas prepared for routine oestrogen receptor (ER) and progesterone receptor (PR) analysis, as well as 31 nipple aspirates from six women with non-diseased mammary glands, were assayed for hK2 and PSA using immunofluorometric assays developed by the authors. In the tumour extracts, measurable hK2 and PSA concentrations were detected in 53% and 73% of cases respectively, and were positively correlated to each other (r = 0.59, P = 0.0001). Higher concentrations of PSA and hK2 were found in tumours expressing steroid hormone receptors (P = 0.0001 for PSA and P = 0.0001 for hK2, by Wilcoxon tests for both ER and PR), and both PSA (r = 0.25, P = 0.0001) and hK2 (r = 0.22, P = 0.0001) correlated directly with PR levels. A negative correlation between patient age and PSA (r = –0.12, P = 0.03) was also found. Both proteins were present in nipple aspirate fluid at relatively high concentrations which were positively correlated (r = 0.53, P = 0.002). The molecular weights of the immunoreactive species quantified by the hK2 and PSA assays were established by high-performance liquid chromatography (HPLC) and were consistent with the known molecular weights of hK2 and PSA. Together these data provide the first evidence, to our knowledge, that both malignant breast tissue and normal breast secretion contain measurable quantities of hK2, and that the degree of hK2 expression or secretion is directly proportional to the expression of PSA and steroid hormone receptors. hK2 expression may therefore be a marker of steroid hormone action in breast tissue. © 2000 Cancer Research Campaign
format Text
id pubmed-2363279
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23632792009-09-10 Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions Black, M H Magklara, A Obiezu, C Levesque, M A Sutherland, D J A Tindall, D J Young, C Y F Sauter, E R Diamandis, E P Br J Cancer Regular Article The recent demonstration of human glandular kallikrein (hK2) expression in a breast carcinoma cell line has suggested that this putatively prostate-restricted, steroid hormone-regulated protease may also be expressed in breast epithelium in vivo and secreted into the mammary duct system. Given that the only substrate yet identified for hK2 activity is the precursor of prostate-specific antigen (PSA), the expression of which in breast carcinomas may be associated with favourable prognosis, our purpose was to examine the expression pattern of both hK2 and PSA in breast tumour tissues. Cytosolic extracts of 336 primary breast carcinomas prepared for routine oestrogen receptor (ER) and progesterone receptor (PR) analysis, as well as 31 nipple aspirates from six women with non-diseased mammary glands, were assayed for hK2 and PSA using immunofluorometric assays developed by the authors. In the tumour extracts, measurable hK2 and PSA concentrations were detected in 53% and 73% of cases respectively, and were positively correlated to each other (r = 0.59, P = 0.0001). Higher concentrations of PSA and hK2 were found in tumours expressing steroid hormone receptors (P = 0.0001 for PSA and P = 0.0001 for hK2, by Wilcoxon tests for both ER and PR), and both PSA (r = 0.25, P = 0.0001) and hK2 (r = 0.22, P = 0.0001) correlated directly with PR levels. A negative correlation between patient age and PSA (r = –0.12, P = 0.03) was also found. Both proteins were present in nipple aspirate fluid at relatively high concentrations which were positively correlated (r = 0.53, P = 0.002). The molecular weights of the immunoreactive species quantified by the hK2 and PSA assays were established by high-performance liquid chromatography (HPLC) and were consistent with the known molecular weights of hK2 and PSA. Together these data provide the first evidence, to our knowledge, that both malignant breast tissue and normal breast secretion contain measurable quantities of hK2, and that the degree of hK2 expression or secretion is directly proportional to the expression of PSA and steroid hormone receptors. hK2 expression may therefore be a marker of steroid hormone action in breast tissue. © 2000 Cancer Research Campaign Nature Publishing Group 2000-01 2000-01-18 /pmc/articles/PMC2363279/ /pubmed/10646889 http://dx.doi.org/10.1054/bjoc.1999.0927 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Black, M H
Magklara, A
Obiezu, C
Levesque, M A
Sutherland, D J A
Tindall, D J
Young, C Y F
Sauter, E R
Diamandis, E P
Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
title Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
title_full Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
title_fullStr Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
title_full_unstemmed Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
title_short Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
title_sort expression of a prostate-associated protein, human glandular kallikrein (hk2), in breast tumours and in normal breast secretions
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363279/
https://www.ncbi.nlm.nih.gov/pubmed/10646889
http://dx.doi.org/10.1054/bjoc.1999.0927
work_keys_str_mv AT blackmh expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT magklaraa expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT obiezuc expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT levesquema expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT sutherlanddja expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT tindalldj expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT youngcyf expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT sauterer expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions
AT diamandisep expressionofaprostateassociatedproteinhumanglandularkallikreinhk2inbreasttumoursandinnormalbreastsecretions